Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis.

Abstract

Authors

• Chao Feng
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Yaobang Wang
  Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
• Wuyue Song
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Tao Liu
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Han Mo
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Hui Liu
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Shulin Wu
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Zezu Qin
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Zhenxing Wang
  Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
• Yuting Tao
  Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
• Liangyu He
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
• Shaomei Tang
  Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
• Yuanliang Xie
  Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
• Qiuyan Wang
  Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
• Tianyu Li
  Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Keywords

External Resources